Selected article for: "Chi square test and ICU admission"

Author: Mazzaccaro, Daniela; Giacomazzi, Francesca; Giannetta, Matteo; Varriale, Alberto; Scaramuzzo, Rosa; Modafferi, Alfredo; Malacrida, Giovanni; Righini, Paolo; Marrocco-Trischitta, Massimiliano M.; Nano, Giovanni
Title: Non-Overt Coagulopathy in Non-ICU Patients with Mild to Moderate COVID-19 Pneumonia
  • Cord-id: av2zj7k8
  • Document date: 2020_6_8
  • ID: av2zj7k8
    Snippet: Introduction: Aim of the study is to assess the occurrence of early stage coagulopathy and disseminated intravascular coagulation (DIC) in patients with mild to moderate respiratory distress secondary to SARS-CoV-2 infection. Materials and methods: Data of patients hospitalized from 18 March 2020 to 20 April 2020 were retrospectively reviewed. Two scores for the screening of coagulopathy (SIC and non-overt DIC scores) were calculated. The occurrence of thrombotic complication, death, and worseni
    Document: Introduction: Aim of the study is to assess the occurrence of early stage coagulopathy and disseminated intravascular coagulation (DIC) in patients with mild to moderate respiratory distress secondary to SARS-CoV-2 infection. Materials and methods: Data of patients hospitalized from 18 March 2020 to 20 April 2020 were retrospectively reviewed. Two scores for the screening of coagulopathy (SIC and non-overt DIC scores) were calculated. The occurrence of thrombotic complication, death, and worsening respiratory function requiring non-invasive ventilation (NIV) or admission to ICU were recorded, and these outcomes were correlated with the results of each score. Chi-square test, receiver-operating characteristic curve, and logistic regression analysis were used as appropriate. p Values < 0.05 were considered statistically significant. Results: Data of 32 patients were analyzed. Overt-DIC was diagnosed in two patients (6.2%), while 26 (81.2%) met the criteria for non-overt DIC. Non-overt DIC score values ≥4 significantly correlated with the need of NIV/ICU (p = 0.02) and with the occurrence of thrombotic complications (p = 0.04). A score ≥4 was the optimal cut-off value, performing better than SIC score (p = 0.0018). Values ≥4 in patients with thrombotic complications were predictive of death (p = 0.03). Conclusions: Overt DIC occurred in 6.2% of non-ICU patients hospitalized for a mild to moderate COVID-19 respiratory distress, while 81.2% fulfilled the criteria for non-overt DIC. The non-overt DIC score performed better than the SIC score in predicting the need of NIV/ICU and the occurrence of thrombotic complications, as well as in predicting mortality in patients with thrombotic complications, with a score ≥4 being detected as the optimal cut-off.

    Search related documents:
    Co phrase search for related documents
    • acute coronary syndrome and lmwh therapy: 1
    • acute coronary syndrome and lmwh weight heparin: 1
    • acute coronary syndrome and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute coronary syndrome and low molecular lmwh weight heparin: 1
    • acute coronary syndrome and lupus anticoagulant: 1
    • acute coronary syndrome and lymphocyte neutrophil: 1, 2
    • acute coronary syndrome and lymphocyte neutrophil ratio: 1, 2
    • liver function and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • liver function and logistic regression test: 1, 2
    • liver function and lupus anticoagulant: 1
    • liver function and lymphocyte neutrophil: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • liver function and lymphocyte neutrophil ratio: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • lmwh dosage and low molecular lmwh weight heparin: 1, 2, 3, 4
    • lmwh therapy and low molecular lmwh weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • lmwh weight heparin and logistic regression: 1, 2, 3
    • lmwh weight heparin and low molecular lmwh weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • lmwh weight heparin and lupus anticoagulant: 1
    • lmwh weight heparin and lymphocyte neutrophil: 1
    • lmwh weight heparin and lymphocyte neutrophil ratio: 1